Abvc Biopharma (ABVC) Receivables - Other (2015 - 2026)
Abvc Biopharma (ABVC) reported Receivables - Other of $1.87 million for Q3 2026, down 3.4% from $1.93 million a year earlier.
Powered by 
Analysis
Abvc Biopharma (ABVC) Receivables - Other (2015 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma posted Receivables - Other of $760,000.
- Receivables - Other has a five-year compound annual growth rate of 39.6% (FY2020 to FY2025).
- By year, Receivables - Other came in at $747,573 in FY2023 (-1.3%), $757,343 in FY2022 (+420.9%) and $145,399 in FY2021 (+1.4%).
- Five-year quarterly Receivables - Other spans a low of $2,667 in Q4 2023 and a high of $2.84 million in Q2 2024.
- Year over year, Receivables - Other has now declined in each of the last three quarters, with an average decline of 35.7% over the last six quarters.
- The high point for year-over-year Receivables - Other in five years was Q2 2024 (growth of 440.6%); the low point was Q4 2023 (a decline of 99.6%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $36,184 (Q2 2026), $167,324 (Q1 2026) and $760,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.87 Mn |
| Jun 30, 2026 | 36,184.00 |
| Mar 31, 2026 | 167,324.00 |
| Dec 31, 2025 | 760,000.00 |
| Sep 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 2.84 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 2,667.00 |
| Sep 30, 2023 | 624,373.00 |
| Jun 30, 2023 | 526,216.00 |
| Mar 31, 2023 | 519,984.00 |
| Dec 31, 2022 | 757,343.00 |
| Sep 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 142,225.00 |
| Mar 31, 2022 | 145,399.00 |
| Dec 31, 2021 | 145,399.00 |
| Sep 30, 2021 | 141,826.00 |
API Access
Abvc Biopharma Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();